tiprankstipranks
Advertisement
Advertisement
Immatics reports Q1 EPS (43c), consensus (44c)
PremiumThe FlyImmatics reports Q1 EPS (43c), consensus (44c)
2M ago
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
Premium
Company Announcements
Immatics Widens Q1 2026 Loss as Collaboration Revenue Drops, R&D Spend Climbs
2M ago
Immatics initiated with a Buy at TD Cowen
Premium
The Fly
Immatics initiated with a Buy at TD Cowen
2M ago
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
PremiumCompany AnnouncementsImmatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance
4M ago
Immatics sees cash runway into 2028
Premium
The Fly
Immatics sees cash runway into 2028
4M ago
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
Premium
The Fly
Immatics reports FY25 EPS (EUR 1.61) vs. EUR 0.14 last year
4M ago
Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
PremiumCompany AnnouncementsImmatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
7M ago
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
Premium
The Fly
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
7M ago
Immatics Completes $116.5 Million Share Offering to Boost R&D
Premium
Company Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100